Search by Drug Name or NDC
NDC 00555-0171-78 Mefloquine Hydrochloride 250 mg/1 Details
Mefloquine Hydrochloride 250 mg/1
Mefloquine Hydrochloride is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is MEFLOQUINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Mefloquine is used to treat malaria (a serious infection that is spread by mosquitoes in certain parts of the world and can cause death) and to prevent malaria in travelers who visit areas where malaria is common. Mefloquine is in a class of medications called antimalarials. It works by killing the organisms that cause malaria.
Related Packages: 00555-0171-78Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Mefloquine
Product Information
NDC | 00555-0171 |
---|---|
Product ID | 0555-0171_33a105c5-0e51-4759-857b-6ca8dfae1d13 |
Associated GPIs | 13000025100310 |
GCN Sequence Number | 013747 |
GCN Sequence Number Description | mefloquine HCl TABLET 250 MG ORAL |
HIC3 | W4A |
HIC3 Description | ANTIMALARIAL DRUGS |
GCN | 42900 |
HICL Sequence Number | 004882 |
HICL Sequence Number Description | MEFLOQUINE HCL |
Brand/Generic | Generic |
Proprietary Name | Mefloquine Hydrochloride |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Mefloquine Hydrochloride |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | TABLET |
Route | ORAL |
Active Ingredient Strength | 250 |
Active Ingredient Units | mg/1 |
Substance Name | MEFLOQUINE HYDROCHLORIDE |
Labeler Name | Teva Pharmaceuticals USA, Inc. |
Pharmaceutical Class | Antimalarial [EPC] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA076392 |
Listing Certified Through | 2024-12-31 |
Package
NDC 00555-0171-78 (00555017178)
NDC Package Code | 0555-0171-78 |
---|---|
Billing NDC | 00555017178 |
Package | 25 BLISTER PACK in 1 CARTON (0555-0171-78) / 1 TABLET in 1 BLISTER PACK (0555-0171-88) |
Marketing Start Date | 2004-01-06 |
NDC Exclude Flag | N |
Pricing Information | |
Price Per Unit | 4.83337 |
Pricing Unit | EA |
Effective Date | 2024-02-21 |
NDC Description | MEFLOQUINE HCL 250 MG TABLET |
Pharmacy Type Indicator | C/I |
OTC | N |
Explanation Code | 1 |
Classification for Rate Setting | G |
As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis